AIMC Topic: Neoplasms

Clear Filters Showing 1991 to 2000 of 2356 articles

Deep centroid: a general deep cascade classifier for biomedical omics data classification.

Bioinformatics (Oxford, England)
MOTIVATION: Classification of samples using biomedical omics data is a widely used method in biomedical research. However, these datasets often possess challenging characteristics, including high dimensionality, limited sample sizes, and inherent bia...

Towards an Explainable AI Platform to Study Interruptions in Cancer Radiation Therapy.

Studies in health technology and informatics
Radiation therapy interruptions drive cancer treatment failures; they represent an untapped opportunity for improving outcomes and narrowing treatment disparities. This research reports on the early development of the X-CART platform, which uses expl...

Preemptive Forecasting of Symptom Escalation in Cancer Patients Undergoing Chemotherapy.

AMIA ... Annual Symposium proceedings. AMIA Symposium
This study evaluates the utility of machine learning (ML) algorithms in early forecasting of total symptom score changes from daily self-reports of 339 chemotherapy patients. The dataset comprised 12 specific symptoms, with severity and distress for ...

Unlocking Early Cancer Detection: Leveraging Machine Learning in Cell-Free DNA Analysis for Precision Oncology.

AMIA ... Annual Symposium proceedings. AMIA Symposium
This study introduces a groundbreaking approach to early cancer detection through the analysis of cell-free DNA (cfDNA), utilizing machine learning algorithms to navigate the complexities of low circulating tumor DNA (ctDNA) fractions and genetic het...

Narrative Feature or Structured Feature? A Study of Large Language Models to Identify Cancer Patients at Risk of Heart Failure.

AMIA ... Annual Symposium proceedings. AMIA Symposium
Cancer treatments are known to introduce cardiotoxicity, negatively impacting outcomes and survivorship. Identifying cancer patients at risk of heart failure (HF) is critical to improving cancer treatment outcomes and safety. This study examined mach...

Artificial Intelligence-assisted Biomedical Literature Knowledge Synthesis to Support Decision-making in Precision Oncology.

AMIA ... Annual Symposium proceedings. AMIA Symposium
The delivery of effective targeted therapies requires comprehensive analyses of the molecular profiling of tumors and matching with clinical phenotypes in the context of existing knowledge described in biomedical literature, registries, and knowledge...

Enhancing Patient Medication Safety at Home: A Patient-Facing Technology Architecture Integrating REDCap, Visualization Dashboards, and an AI- Driven Chatbot.

AMIA ... Annual Symposium proceedings. AMIA Symposium
This work demonstrates a novel architecture for a patient-facing technology (PFT) that supports patients with cancer in self-managing medication concerns and symptoms after care transitions back home. Patient-generated data are collected and stored u...